Lophos Holdings (XCNQ:MESC) YoY EBITDA Growth : -33.33% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Lophos Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Lophos Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -33.33%.

Lophos Holdings's EBITDA per Share for the three months ended in Mar. 2024 was C$-0.00.

Lophos Holdings YoY EBITDA Growth Historical Data

The historical data trend for Lophos Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lophos Holdings YoY EBITDA Growth Chart

Lophos Holdings Annual Data

Trend

Mar22

Mar23

Mar24

YoY EBITDA Growth

-33.33

Lophos Holdings Quarterly Data
	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial				-	-33.33	-50.00	50.00	-33.33

Lophos Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Lophos Holdings's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(-0.012	-	-0.009)	/	\| -0.009 \|
=	-33.33 %

Lophos Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.004	-	-0.003)	/	\| -0.003 \|
=	-33.33 %

Lophos Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Lophos Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lophos Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

1111 Melville Street, Suite 620, Vancouver, BC, CAN, V6E 3V6

Website

Lophos Holdings Inc is engaged in the y is the cultivation of peyote and the manufacture of Lophophora compounds, including Mescaline, as well as formulation of novel Lophophora-based compounds.

Executives

John Ioannis Karagiannidis	Director
Evan Stawnyczy	Director

Lophos Holdings Headlines

No Headlines